Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Stump

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Cancer Research|January 1, 1991
Occurrence of components of fibrinolysis pathways in situ in neoplastic and nonneoplastic human breast tissueV Costantini, L R Zacharski, V A Memoli, et al.
Thrombosis and Haemostasis|November 30, 1990
Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombinD M Abercrombie, B Buchinski, K A Salvato, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1990
Pathologic fibrinolysis as a cause of clinical bleedingD C Stump, F B Taylor, M E Nesheim, et al.
Blood|October 1, 1990
Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarctionC M Lawler, E G Bovill, D C Stump, et al.
Annals of Internal Medicine|December 15, 1989
Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and managementD C Sane, R M Califf, E J Topol, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1992
Fibrinogen deposition and macrophage-associated fibrin formation in malignant and nonmalignant lymphoid tissueV Costantini, L R Zacharski, V A Memoli, et al.
Circulation|November 1, 1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study GroupD C Stump, R M Califf, E J Topol, et al.
Journal of the American College of Cardiology|July 1, 1986
Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasisW Flameng, J Vanhaecke, D C Stump, et al.
American Journal of Clinical Pathology|April 1, 1990
Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situM Z Wojtukiewicz, L R Zacharski, V A Memoli, et al.
Cancer|February 1, 1990
Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lungM Z Wojtukiewicz, L R Zacharski, V A Memoli, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Cancer Research|January 1, 1991
Occurrence of components of fibrinolysis pathways in situ in neoplastic and nonneoplastic human breast tissueV Costantini, L R Zacharski, V A Memoli, et al.
Thrombosis and Haemostasis|November 30, 1990
Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombinD M Abercrombie, B Buchinski, K A Salvato, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1990
Pathologic fibrinolysis as a cause of clinical bleedingD C Stump, F B Taylor, M E Nesheim, et al.
Blood|October 1, 1990
Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarctionC M Lawler, E G Bovill, D C Stump, et al.
Annals of Internal Medicine|December 15, 1989
Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and managementD C Sane, R M Califf, E J Topol, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1992
Fibrinogen deposition and macrophage-associated fibrin formation in malignant and nonmalignant lymphoid tissueV Costantini, L R Zacharski, V A Memoli, et al.
Circulation|November 1, 1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study GroupD C Stump, R M Califf, E J Topol, et al.
Journal of the American College of Cardiology|July 1, 1986
Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasisW Flameng, J Vanhaecke, D C Stump, et al.
American Journal of Clinical Pathology|April 1, 1990
Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situM Z Wojtukiewicz, L R Zacharski, V A Memoli, et al.
Cancer|February 1, 1990
Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lungM Z Wojtukiewicz, L R Zacharski, V A Memoli, et al.
Pageof 6